Scarica l'app Stockscreener
11.90
2.42%
-0.27
Precedente Chiudi:
$12.17
Aprire:
$12.18
Volume 24 ore:
2,707
Relative Volume:
0.05
Capitalizzazione di mercato:
$282.54M
Reddito:
$59,000
Utile/perdita netta:
$-21.81M
Rapporto P/E:
-1.0866
EPS:
-10.9518
Flusso di cassa netto:
$-18.07M
1 W Prestazione:
+9.25%
1M Prestazione:
-1.86%
6M Prestazione:
+48.81%
1 anno Prestazione:
+293.21%
Intervallo 1D:
$11.89
$12.18
Intervallo di 1 settimana:
$10.75
$12.30
Portata 52W:
$2.70
$13.29
Benitec Biopharma Inc Stock (BNTC) Company Profile
Nome
Benitec Biopharma Inc
Settore
Industria
Telefono
(510) 780-0819
Indirizzo
3940 TRUST WAY, HAYWARD, CA
Confronta BNTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
11.90 | 282.54M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.06 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.83 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
666.50 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.00 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
121.01 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-10-16 | Iniziato | Oppenheimer | Outperform |
| 2024-09-12 | Iniziato | Guggenheim | Buy |
| 2024-07-22 | Iniziato | Leerink Partners | Outperform |
| 2024-06-13 | Iniziato | Piper Sandler | Overweight |
| 2020-10-05 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-02-26 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-31 | Reiterato | Maxim Group | Buy |
| 2015-09-16 | Reiterato | Maxim Group | Buy |
Mostra tutto
Benitec Biopharma Inc Borsa (BNTC) Ultime notizie
Institutional investors are Benitec Biopharma Inc.'s (NASDAQ:BNTC) biggest bettors and were rewarded after last week's US$33m market cap gain - Simply Wall St
Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
Benitec Biopharma (BNTC) to Release Earnings on Monday - MarketBeat
(BNTC) Technical Pivots with Risk Controls - Stock Traders Daily
Franklin Resources Inc. Acquires Significant Stake in Benitec Bi - GuruFocus.com
Benitec Biopharma to Participate in Upcoming Conferences in January and February - GlobeNewswire
BNTCBenitec Biopharma Inc. Latest Stock News & Market Updates - StockTitan
Benitec Biopharma Announces Three Major Conference Presentations for Early 2025 - StockTitan
Guggenheim Initiates Coverage of Benitec Biopharma (BNTC) with Buy Recommendation - MSN
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Given Average Rating of “Buy” by Brokerages - Defense World
Benitec Biopharma: Early Positive Data, Small Target Market, Little Competition - Seeking Alpha
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Update - MarketBeat
Why You Shouldn't Bet Against Benitec Biopharma (BNTC) Stock - MSN
Benitec Biopharma Inc. (NASDAQ:BNTC) Shares Purchased by Geode Capital Management LLC - Defense World
Benitec Biopharma (NASDAQ:BNTC) Stock Crosses Below 50 Day Moving AverageTime to Sell? - MarketBeat
(BNTC) Proactive Strategies - Stock Traders Daily
Top 5 Small-cap Biotech Stocks (Updated January 2025) - Investing News Network
Brokerages Set Benitec Biopharma Inc. (NASDAQ:BNTC) Price Target at $24.43 - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Average Rating of “Buy” from Analysts - Defense World
How To Trade (BNTC) - Stock Traders Daily
Benitec Biopharma Inc. (NASDAQ:BNTC) Director Buys $301,971.96 in Stock - MarketBeat
Suvretta capital management buys $527,174 in Benitec Biopharma stock - Investing.com
Recent Price Trend in Benitec Biopharma (BNTC) is Your Friend, Here's Why - Yahoo Finance
Equities Analysts Issue Forecasts for BNTC Q2 Earnings - Defense World
Q2 Earnings Estimate for BNTC Issued By HC Wainwright - MarketBeat
Where are the Opportunities in (BNTC) - Stock Traders Daily
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) - Yahoo Finance
Benitec Biopharma stock soars to 52-week high of $13.29 By Investing.com - Investing.com South Africa
Benitec Biopharma stock soars to 52-week high of $13.29 - Investing.com
Benitec Biopharma (NASDAQ:BNTC) Now Covered by HC Wainwright - Defense World
Benitec Biopharma initiated with a Buy at H.C. Wainwright - Yahoo Finance
Benitec Biopharma's SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com
Benitec Biopharma announces executive team changes - Investing.com
Benitec Biopharma (NASDAQ:BNTC) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat
Benitec Biopharma (NASDAQ:BNTC) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Benitec Biopharma announces executive team changes By Investing.com - Investing.com Australia
Benitec Biopharma (NASDAQ:BNTC) Appoints New Chief Operating Officer and Makes Changes to Executive Officers’ Roles and Compensation - Defense World
Short Interest in Benitec Biopharma Inc. (NASDAQ:BNTC) Grows By 6.9% - MarketBeat
Robert W. Baird Begins Coverage on Benitec Biopharma (NASDAQ:BNTC) - Defense World
Benitec Biopharma Shakes Up Management Team - MarketWatch
Baird Initiates Coverage of Benitec Biopharma (BNTC) with Outperform Recommendation - MSN
Benitec Biopharma (NASDAQ:BNTC) Coverage Initiated at Robert W. Baird - MarketBeat
Baird sets $30 target on Benitec BioPharma, cites gene therapy By Investing.com - Investing.com UK
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
Benitec Biopharma approves preferred stock issuance By Investing.com - Investing.com Canada
Benitec Biopharma approves preferred stock issuance - Investing.com
Benitec Biopharma stock soars to 52-week high of $12.95 By Investing.com - Investing.com Canada
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? - Yahoo Finance
When (BNTC) Moves Investors should Listen - Stock Traders Daily
Benitec Biopharma shareholders approve key proposals By Investing.com - Investing.com Canada
Benitec Biopharma Inc Azioni (BNTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Benitec Biopharma Inc Azioni (BNTC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
0.40%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):